Back to Search
Start Over
Collapsin response mediator protein 4 promotor methylation level as a potential predictor for diagnosing primary malignant lymphoma of the prostate
- Source :
- Cancer Cell International, Vol 18, Iss 1, Pp 1-10 (2018), Cancer Cell International
- Publication Year :
- 2018
- Publisher :
- BMC, 2018.
-
Abstract
- Background Primary malignant lymphoma of the prostate (PMLP) is prone to occur in the elderly, and it has no significant correlation with lactate dehydrogenase (LDH) and prostate specific antigen (PSA). Clinical symptoms and imaging data of PMLP remain unspecific, and its prognosis is poor. A previous result showed that collapsin response mediator protein 4 (CRMP4) promotor methylation can be used as a predictor for lymph node metastases in prostate biopsies. However, the relationship between CRMP4 promotor methylation and PMLP has not been studied. Methods We investigated the clinicopathological features of PMLP and the significance of CRMP4 methylation in PMLP. The clinical data and diagnosis information of 10 patients with PMLP were retrospectively analyzed. The CRMP4 promotor methylation level in paraffin-embedded tissues of the 10 patients with PMLP were determined and then compared to limited prostate cancer (LPCa) and its negative lymph node tissue [LPCa-LN (−) (10 cases)] and also to metastatic prostate adenocarcinoma (mPCa) and its positive lymph node tissue [mPCa-LN (+) (10 cases)]. Methylation of the CRMP4 promotor in each group was analyzed statistically. A receiver operating characteristic (ROC) curve was used to analyze the diagnostic value of CRMP4 methylation in PMLP. Results The average methylation value of CRMP4 in 10 PMLP patients, 20 cases of prostate adenocarcinoma tissue, 10 cases LPCa-LN (−) and 10 cases mPCa-LN (+) were 42.3, 30.6, 6.7 and 20.3%, respectively. A Kruskal–Wallis test showed that the difference of CRMP4 methylation was significant (X2 = 38.0, P 40.9% could diagnose PMLP. This method had 90% sensitivity and 95% specificity under conditions of CRMP4 methylation > 40.9%. The area under the curve (AUC) was 0.957. Conclusions Methylation of the CRMP4 gene was significantly increased in PMLP, and it is expected to become a new predictor for PMLP.
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
030232 urology & nephrology
Methylation
lcsh:RC254-282
03 medical and health sciences
chemistry.chemical_compound
Prostate cancer
0302 clinical medicine
Prostate
Lactate dehydrogenase
Internal medicine
Genetics
medicine
lcsh:QH573-671
Lymph node
Receiver operating characteristic
business.industry
lcsh:Cytology
Area under the curve
Primary malignant lymphoma prostate (PMLP)
medicine.disease
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
ROC curve
Prostate-specific antigen
medicine.anatomical_structure
chemistry
030220 oncology & carcinogenesis
Primary Research
business
Collapsin response mediator protein 4 (CRMP4)
Predictor
Subjects
Details
- Language :
- English
- ISSN :
- 14752867
- Volume :
- 18
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Cancer Cell International
- Accession number :
- edsair.doi.dedup.....4fc96b194cfedf78883bbc48e0b23e69
- Full Text :
- https://doi.org/10.1186/s12935-017-0484-9